Cargando…

A Prediction Model for Tumor Recurrence in Stage II–III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling

Background: Colorectal cancer (CRC) is one of the most prevalent malignant diseases worldwide. Risk prediction for tumor recurrence is important for making effective treatment decisions and for the survival outcomes of patients with CRC after surgery. Herein, we aimed to explore a prediction algorit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Po-Chuan, Yeh, Yu-Min, Lin, Bo-Wen, Chan, Ren-Hao, Su, Pei-Fang, Liu, Yi-Chia, Lee, Chung-Ta, Chen, Shang-Hung, Lin, Peng-Chan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961774/ https://www.ncbi.nlm.nih.gov/pubmed/35203549 http://dx.doi.org/10.3390/biomedicines10020340

Ejemplares similares

Intratumor Heterogeneity of MYO18A and FBXW7 Variants Impact the Clinical Outcome of Stage III Colorectal Cancer
por: Lin, Peng-Chan, et al.
Publicado: (2020)

Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy
por: Lin, Peng-Chan, et al.
Publicado: (2021)

PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer—Its Clinical and Biological Significance in Immune Microenvironment
por: Chung, Bing-Syuan, et al.
Publicado: (2022)

Treatment monitoring of colorectal cancer by integrated analysis of plasma concentration and sequencing of circulating tumor DNA
por: Yeh, Yu-Min, et al.
Publicado: (2020)

Adjusted CT Image-Based Radiomic Features Combined with Immune Genomic Expression Achieve Accurate Prognostic Classification and Identification of Therapeutic Targets in Stage III Colorectal Cancer
por: Huang, Yi-Ching, et al.
Publicado: (2022)

Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer
por: Chan, Ren-Hao, et al.
Publicado: (2021)

Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer
por: Lin, Peng-Chan, et al.
Publicado: (2019)

Identification of a ferroptosis-related gene signature predicting recurrence in stage II/III colorectal cancer based on machine learning algorithms
por: Wang, Ze, et al.
Publicado: (2023)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
por: Posch, Florian, et al.
Publicado: (2017)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer
por: Lin, Peng-Chan, et al.
Publicado: (2020)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Prognostic Significance of Perineural Invasion in Patients with Stage II/III Gastric Cancer Undergoing Radical Surgery
por: Chen, Yi-Fu, et al.
Publicado: (2022)

Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer
por: Huang, Yi-Hsuan, et al.
Publicado: (2021)

Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy
por: Chang, Yu-Tang, et al.
Publicado: (2023)

The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
por: Xu, Guozeng, et al.
Publicado: (2021)

Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma
por: Liu, Gang, et al.
Publicado: (2017)

Identifying Stage II Colorectal Cancer Recurrence Associated Genes by Microarray Meta-Analysis and Building Predictive Models with Machine Learning Algorithms
por: Lu, Wei, et al.
Publicado: (2021)

Hypomethylation-Associated Up-Regulation of TCF3 Expression and Recurrence in Stage II and III Colorectal Cancer
por: Li, Chunxiang, et al.
Publicado: (2014)

Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing
por: Kishigami, Fumishi, et al.
Publicado: (2022)

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer
por: Xin, Cheng, et al.
Publicado: (2023)

Machine learning based prognostic model of Chinese medicine affecting the recurrence and metastasis of I-III stage colorectal cancer: A retrospective study in China
por: Tang, Mo, et al.
Publicado: (2022)

Diagnostic Accuracy of Elevated Serum Carcinoembryonic Antigen for Recurrence in Postoperative Stage II Colorectal Cancer Patients: Comparison With Stage III
por: Kim, Ho Seung, et al.
Publicado: (2013)

CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer
por: Hsieh, Chi-Che, et al.
Publicado: (2022)

Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery
por: Huang, Mingliang, et al.
Publicado: (2022)

Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer
por: Cavalleri, Tommaso, et al.
Publicado: (2022)

Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer
por: Wang, Dong, et al.
Publicado: (2019)

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer
por: Wang, De‐shen, et al.
Publicado: (2019)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
por: Viñal, David, et al.
Publicado: (2022)

Novel Model to Predict the Prognosis of Patients with Stage II–III Colon Cancer
por: Xu, Yansong, et al.
Publicado: (2020)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2018)

Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer
por: Chen, Feng, et al.
Publicado: (2021)

Risk factors for postoperative recurrence in patients with stage II colorectal cancer
por: Xiong, Zhi-Zhong, et al.
Publicado: (2023)

Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
por: Lin, Po-Han, et al.
Publicado: (2021)

Adjuvant Chemotherapy Improves Survival in Stage III Gastric Cancer after D2 Surgery
por: Chang, Shin-Chun, et al.
Publicado: (2018)

The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal Cancer
por: Chan, Ren-Hao, et al.
Publicado: (2022)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2t5sd7rpmtrqr5ovtg4p8uup9f